News | 7/11/2018

Health Advances Team Publishes Compelling Economic Data for Tactile Medical

The study design was a longitudinal matched case-control analysis utilizing de-identified private insurance claims information from Blue Health Intelligence. Julia Gaebler will present the results of the study with Blue Health Intelligence CEO, Swati Abbott, at the 14th annual Medical Device and Reimbursement Conference in Chicago, IL on July 11, 2018.

The results, published in the Journal of Vascular Surgery, document that Tactile’s Flexitouch saves 85% of per year lymphedema- and sequelae-related costs vs. simple pneumatic compression devices and 53% vs. advanced pneumatic compression devices. This publication will bolster Tactile’s market access and support its future pricing. As Gerald Mattys, Tactile’s CEO, stated: “These data highlight the dramatic positive impact of our Flexitouch system on healthcare utilization and costs in a large and important patient population.”

Health Advances often works with clients to document the economic implications of utilizing their technologies so that they can maximize pricing while gaining rapid and attractive coverage decisions.

Read the article.